Los Angeles Capital Management LLC Blueprint Medicines Corp Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

A detailed history of Los Angeles Capital Management LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 11,179 shares of BPMC stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,179

Previous 14,439 22.58%

Holding current value

$1.08 Million

Previous $1.56 Million 33.61%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$84.1 - $120.5 $274,166 - $392,830	-3,260 Reduced 22.58%	11,179 $1.03 Million
Q2 2024 Aug 05, 2024	SELL	$85.18 - $108.78 $5,451 - $6,961	-64 Reduced 0.44%	14,439 $1.56 Million
Q1 2024 Apr 05, 2024	BUY	$73.17 - $99.79 $731 - $997	10 Added 0.07%	14,503 $1.38 Million
Q3 2023 Nov 06, 2023	BUY	$46.9 - $66.0 $16,649 - $23,430	355 Added 2.51%	14,493 $727,000
Q2 2023 Aug 03, 2023	BUY	$42.2 - $66.37 $340,849 - $536,070	8,077 Added 133.26%	14,138 $893,000
Q1 2023 May 04, 2023	BUY	$37.97 - $50.0 $34,135 - $44,950	899 Added 17.42%	6,061 $272,000
Q4 2022 Feb 06, 2023	SELL	$41.06 - $66.48 $24,636 - $39,888	-600 Reduced 10.41%	5,162 $226,000
Q3 2022 Nov 02, 2022	BUY	$49.93 - $77.7 $287,696 - $447,707	5,762 New	5,762 $380,000
Q1 2022 May 06, 2022	SELL	$54.1 - $110.08 $851,101 - $1.73 Million	-15,732 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$94.25 - $115.99 $16,399 - $20,182	-174 Reduced 1.09%	15,732 $1.69 Million
Q2 2021 Aug 05, 2021	SELL	$82.78 - $101.0 $288,902 - $352,490	-3,490 Reduced 17.99%	15,906 $1.4 Million
Q1 2021 May 05, 2021	SELL	$90.71 - $108.28 $1.23 Million - $1.47 Million	-13,555 Reduced 41.14%	19,396 $1.89 Million
Q4 2020 Feb 04, 2021	SELL	$92.08 - $124.48 $141,803 - $191,699	-1,540 Reduced 4.46%	32,951 $3.7 Million
Q3 2020 Nov 02, 2020	SELL	$66.45 - $92.7 $421,027 - $587,347	-6,336 Reduced 15.52%	34,491 $3.2 Million
Q2 2020 Aug 05, 2020	BUY	$57.09 - $79.27 $989,027 - $1.37 Million	17,324 Added 73.71%	40,827 $3.18 Million
Q1 2020 May 04, 2020	BUY	$48.11 - $82.22 $310,213 - $530,154	6,448 Added 37.81%	23,503 $1.37 Million
Q4 2019 Feb 07, 2020	SELL	$66.73 - $82.59 $164,155 - $203,171	-2,460 Reduced 12.61%	17,055 $1.37 Million
Q3 2019 Nov 07, 2019	SELL	$72.9 - $101.41 $130,491 - $181,523	-1,790 Reduced 8.4%	19,515 $1.43 Million
Q2 2019 Jul 29, 2019	BUY	$73.54 - $97.8 $251,139 - $333,987	3,415 Added 19.09%	21,305 $2.01 Million
Q1 2019 Apr 25, 2019	BUY	$48.7 - $86.6 $78,650 - $139,859	1,615 Added 9.92%	17,890 $1.43 Million
Q4 2018 Feb 11, 2019	SELL	$45.57 - $74.26 $269,546 - $439,247	-5,915 Reduced 26.66%	16,275 $877,000
Q3 2018 Nov 05, 2018	SELL	$58.91 - $78.32 $238,585 - $317,196	-4,050 Reduced 15.43%	22,190 $1.73 Million
Q2 2018 Jul 31, 2018	BUY	$60.96 - $101.18 $1.23 Million - $2.05 Million	20,230 Added 336.61%	26,240 $1.67 Million
Q1 2018 Apr 27, 2018	BUY	$73.28 - $102.95 $440,412 - $618,729	6,010 New	6,010 $551,000

Others Institutions Holding BPMC

# of Institutions

350

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.77B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Blueprint Medicines Corp Transaction History